Donovan Weighs in on the Defining Pandemic Moments For Health And Life Science Attorneys
11 March 2021
Law360
Partner Christopher J. Donovan was quoted in a Law360 article titled, “The Defining Pandemic Moments For Health And Life Sci Attys.” The article solicited recollections from attorneys about the unprecedented impacts of the COVID-19 pandemic and how it tested and profoundly reshaped our health care and life sciences systems.
One such impact was a decline in health care M&A activity in early months of the pandemic. However, Donovan told Law360 that M&A “came back with a vengeance in Q3-Q4 of 2020. He added that the shift to virtual meetings provided greater flexibility for bankers and PE investors who could suddenly, “”visit four cities in one day” for meetings, Donovan added.
People
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."